The US Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) issued a notice of proposed rulemaking (NPRM) for the fourth extension of a waiver for prescribing controlled substances via telemedicine for patients without a prior in-person visit.
The temporary rule ensures that people who rely
Register for free to keep reading
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day